LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun reviewing a prefilled syringe form of Shingrix, GSK's vaccine for shingles ...
GSK takes advantage of natural experiment to study whether shingles vaccine can reduce dementia risk
After multiple studies have suggested a link between its shingles vaccine and dementia prevention, GSK is taking advantage of a natural experiment to look for more definitive evidence that the shot ...
Researchers investigated whether the shingles (herpes zoster) vaccine can help prevent dementia. Previous studies suggest that certain herpes viruses may contribute to dementia, and vaccines might ...
GSK Plc is studying a large group of elderly adults in the UK to determine if its blockbuster shingles vaccine reduces the risk of dementia, potentially opening the door to an expanded label for the ...
GSK (NYSE:GSK) announced Thursday that the U.S. Food and Drug Administration (FDA) approved a new prefilled syringe presentation of its shingles vaccine, Shingrix, offering a convenient administration ...
KUTV — The following information was submitted by GSK. The holidays are here, and there’s no better time to give yourself the gift of staying healthy. An important preventative step is to stay up to ...
GlaxoSmithKline gained U.S. and Canadian regulatory approval for Shingrix in October, as well as European Union and Japanese regulatory approval in March. The vaccine is considered by the CDC to be at ...
PORTLAND, Ore (KOIN) – On behalf of our sponsors at GSK, we’re learning that an estimated one million Americans develop Shingles each year. It’s important for those over the age of 50 to find out ...
GSK PLCGSK-1.13%decrease; red down pointing triangle extended its collaboration with Chongqing Zhifei Biological Products 300122-2.80%decrease; red down pointing triangle to commercialize its shingles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback